Menu
LONVIA CAPITAL was born as an independent manager with a long-term investment philosophy. The team consists of Cyrille Carriére, Cyril de Vanssay, Jacques Gout-Lombard and Dorian Terral.
The objective of the new fund is to achieve long-term capital growth, protecting it in bearish situations, it selects companies that suffer price anomalies in different geographical areas of developed and EM.
The new fund will invest in innovative companies who they believe are able to drive outsized investment returns by capturing the bulk of the economic value created by waves of innovation.
The institute launched by Calvert Research and Management, a global leader in responsible investing, will offer internal research and education programmes, and partner with leading academic organisations, industry groups and other like-minded investors to create and sponsor third-party research.
The portfolio seeks to generate superior long-term returns by providing investors exposure to global companies at the forefront of rapid innovation in health care.
The three new funds aim to address inefficiencies such as high turnover and high transaction costs in fixed income that make it very difficult for both active and passive managers to deliver index returns.
Themes
Book now